Royal Bank of Canada’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35K | Buy |
8,948
+4,178
| +88% | +$16.3K | ﹤0.01% | 5691 |
|
|
2025
Q1 | $4K | Sell |
4,770
-3,807
| -44% | -$3.19K | ﹤0.01% | 6024 |
|
|
2024
Q4 | $23K | Buy |
8,577
+3,053
| +55% | +$8.19K | ﹤0.01% | 5563 |
|
|
2024
Q3 | $29K | Buy |
5,524
+227
| +4% | +$1.19K | ﹤0.01% | 5490 |
|
|
2024
Q2 | $24K | Buy |
5,297
+3,291
| +164% | +$14.9K | ﹤0.01% | 5600 |
|
|
2024
Q1 | $15K | Sell |
2,006
-13,096
| -87% | -$97.9K | ﹤0.01% | 5587 |
|
|
2023
Q4 | $64K | Buy |
15,102
+9,419
| +166% | +$39.9K | ﹤0.01% | 5341 |
|
|
2023
Q3 | $24K | Buy |
5,683
+1,743
| +44% | +$7.36K | ﹤0.01% | 5622 |
|
|
2023
Q2 | $22K | Buy |
+3,940
| New | +$22K | ﹤0.01% | 5708 |
|
|
2022
Q4 | – | Sell |
-690
| Closed | -$2K | – | 6927 |
|
|
2022
Q3 | $2K | Buy |
690
+221
| +47% | +$641 | ﹤0.01% | 6533 |
|
|
2022
Q2 | $2K | Sell |
469
-415
| -47% | -$1.77K | ﹤0.01% | 6487 |
|
|
2022
Q1 | $4K | Sell |
884
-2,127
| -71% | -$9.62K | ﹤0.01% | 6831 |
|
|
2021
Q4 | $20K | Buy |
3,011
+1,170
| +64% | +$7.77K | ﹤0.01% | 6273 |
|
|
2021
Q3 | $21K | Buy |
1,841
+857
| +87% | +$9.78K | ﹤0.01% | 6152 |
|
|
2021
Q2 | $17K | Sell |
984
-139
| -12% | -$2.4K | ﹤0.01% | 6138 |
|
|
2021
Q1 | $22K | Buy |
1,123
+861
| +329% | +$16.9K | ﹤0.01% | 5868 |
|
|
2020
Q4 | $5K | Buy |
262
+252
| +2,520% | +$4.81K | ﹤0.01% | 6078 |
|
|
2020
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6223 |
|